Prognostic significance of the histornorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia

被引:0
作者
Lamba, Amit [2 ]
Dey, Pranab [1 ]
Kumari, Savita [3 ]
Marwaha, Neelam [4 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Cytol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Pathol, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India
[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh 160012, India
来源
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY | 2007年 / 29卷 / 06期
关键词
image morphometry; leukemia; chronic myeloid; histomorphometry; prognosis;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To study the correlation of histomorphometric data of bone marrow trephine biopsies at the time of initial diagnosis in chronic myeloid leukemia (CML) patients with the patient prognosis. STUDY DESIGN: A total of 40 CML patients were divided equally in group I (developed accelerated phase or blast crisis within 18 months of initial diagnosis of chronic phase of CML) and group II (developed accelerated phase or blast crisis > 30 months after initial diagnosis of chronic phase of CML). The clinical, hematologic and histomorphometric data were compared in the 2 groups of CML patients. RESULTS: The percentage of bone marrow promyelocytes was significantly increased in group L On morphometry, the number of blasts per square millimeter, the area of reticulin fibers per square millimeter and the percentage area occupied by reticulin fibers were statistically significant. CONCLUSION. There seems to be grounds for hope for predicting prognosis of CML patients at initial diagnosis based on histomorphometric findings. The percentage area of reticulin fibers and the number of blasts per square millimeter are important prognostic predictors in histomorphometry data.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 23 条
[1]  
BRADBURY P, 2002, THEORY PRACTICE HIST, P139
[2]   Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia [J].
Buesche, G ;
Georgii, A ;
Duensing, A ;
Schmeil, A ;
Schlue, J ;
Kreipe, HH .
HUMAN PATHOLOGY, 2003, 34 (04) :391-401
[3]  
CERVANTES F, 1982, BLOOD, V60, P1298
[4]   MYELOFIBROSIS IN CHRONIC GRANULOCYTIC-LEUKEMIA [J].
CLOUGH, V ;
GEARY, CG ;
HASHMI, K ;
DAVSON, J ;
KNOWLSON, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (04) :515-&
[5]   Spotlight on imatinib mesylate in chronic myeloid leukemia [J].
Curran, MP ;
Croom, KF ;
Goa, KL .
BIODRUGS, 2004, 18 (03) :207-210
[6]  
DEKMEZIAN R, 1987, CANCER, V59, P1739, DOI 10.1002/1097-0142(19870515)59:10<1739::AID-CNCR2820591011>3.0.CO
[7]  
2-2
[8]  
GOMEZ GA, 1981, CANCER-AM CANCER SOC, V47, P2470, DOI 10.1002/1097-0142(19810515)47:10<2470::AID-CNCR2820471026>3.0.CO
[9]  
2-0
[10]  
KANTARJIAN HM, 1986, CANCER, V58, P2023, DOI 10.1002/1097-0142(19861101)58:9<2023::AID-CNCR2820580912>3.0.CO